Wondering if any institutions have a policy or procedure for assessing the continuation of home oral chemotherapy agents when admitted from home? We have seen a couple instances of patients being continued on their home chemotherapy, when the likely reason for admission were adverse effects of their oral chemotherapy that were not immediately recognized on admission. Does anyone hold oral chemotherapy orders to be assessed the next day by an oncologist? Open to other policies or procedures, thoughts or suggestions as well. Thanks.

Hello,
Does anyone put Kcentra vials in their ADCs for administration via IV push? If so, how do you capture the exact number of units administered for billing?

Thank you,
Nicole Lloyd

Wondering if anyone has a policy or procedure in place to assess for appropriateness of continuing oral chemotherapy when admitted from home? We have seen a couple instances of patients being admitted for adverse effects from their home medication and the offending medication is being continued upon admission. Does anyone hold the medication upon admission until a oncology specialist or oncologist can review prior to continuing? Other procedures?

Jenni Shahan, PharmD, BCPPS
Medication Safety Specialist
WVUMedicine

With the increase in medications given EUA status for COVID, what is your process for receiving, monitoring, and communicating EUA updates and action items to involved staff? including regularly checking Fact Sheets and keeping EHR systems updated. Thanks!

With the increase in medications given EUA status for COVID, what is your process for receiving, monitoring, and communicating EUA updates and action items to involved staff? including regularly checking Fact Sheets and keeping EHR systems updated. Thank you!

With the increase in medications given EUA status for COVID, what is your process for receiving, monitoring, and communicating EUA updates and action items to involved staff? including regularly checking Fact Sheets and keeping the EHR systems updated. Thank you!

When you compound your chemotherapy preparations, do you account for overfill vs the final labeled volume?
1. Remove "estimated" volume of overfill.
2. Add "estimated" volume of overfill to the final volume on the label.
3. Pump bags to exact base fluid volume stated on the label.
4. Do not account for overfill in the final volume stated on the label.

Hi all -
For those centers that have Omnicell workstations in the OR, how do you display the medication concentration on the labels that print upon removal? Ideally we'd like to see the the quantity per total volume, followed in close proximity by quantity per milliliter enclosed by parentheses (quantity/mL). However, we have character and configuration limitations. Anesthesiology would prefer the display ox x mg/ml rather than the quantity per total volume.
Thanks-
Maria Cumpston, PharmD, CPPS
Medication Safety Officer
WVU Medicine

New recommendations allow for a second 50 mg IVP dose of alteplase in patients in cardiac arrest with known or high suspicion for PE, who had objective evidence response to the first alteplase 50 mg IVP dose but did not sustain ROSC. Pharmacy currently prepares the first 50 mg IVP, outside of our system ED locations, in a syringe as ready-to-administer with goal availability from request to delivery of <15 min.

New recommendations allow for a second 50 mg IVP dose of alteplase in patients in cardiac arrest with known or high suspicion for PE, who had objective evidence response to the first alteplase 50 mg IVP dose but did not sustain ROSC. Pharmacy currently prepares the first 50 mg IVP, outside of our system ED locations, in a syringe as ready-to-administer with goal availability from request to delivery of <15 min.